Drawing for BINX CHECK

USPTO serial 88338099

BINX CHECK

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
KIDWELL WALKER, JACLYN NOEMI
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BINX CHECK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Medical conditions screening kits composed of medical diagnostic reagents and assays for testing of bodily fluids for use in detection STD's and human papillomavirus and prostate-specific antigen, the aforementioned being for use in testing for the presence of infection and disease state health markers in human samples in clinical applications, in animal samples in veterinary applications, and in testing for the presence of infection-causing microorganisms in environmental applicationsACTIVE
010Medical diagnostic kits for medical purposes consisting of medical specimen collection devices for testing the presence of biomarkers indicative of disease, medical conditions and levels of substances, namely, STDs, cancer genetic markers, fertility, and lifestyle concerns; Instrument and apparatus system for medical diagnostic use consisting of medical specimen collection devices, an electronic instrument, a disposable cartridge on which the test is performed in conjunction with the instrument and a range of medical devices used for sample collection to provide the test material, all sold to be used as a unit; the aforementioned systems are for use in testing for the presence of infection and disease state health markers in human samples in clinical applications, in animal samples in veterinary applications, and in testing for the presence of infection-causing microorganisms in environmental applicationACTIVE
044Medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring, and reporting services; medical diagnostic testing for biomarkers indicative of disease, STDs, cancer, genetic anomalies and disorders, fertility, and lifestyle issues, namely, collecting biological samples for in-home testing for medical purposes, providing testing and diagnostic services thereto for medical purposes, and medical information services, namely, reporting test results to customers test kitsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 8, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 8, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 15, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 20, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 31, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 15, 2019ALIEASSIGNED TO LIE
Jul 3, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 24, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2019DOCKASSIGNED TO EXAMINER
Apr 1, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2019NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance